The effectiveness and safety of intra-articular injection of sodium hyaluronate (500-730 kDa) in the treatment of patients with painful knee osteoarthritis

Journal of the Medical Association of Thailand

Volumn 92, Issue 10, 2009, Pages 1287-1294

  Phiphobmongkol, Vajara ^a   Sudhasaneya, Vudhipong ^a  

^a BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

Author keywords

Hyaluronic acid; Knee osteoarthritis; Pain; Sodium hyaluronate

Indexed keywords

HYALURONIC ACID; PARACETAMOL;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; PAIN; RIGIDITY; SCORING SYSTEM; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

AGED; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 70350457510     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-1994. J Rheumatol 2006; 33: 2271-2279
2. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cartilage 1993; 1: 85-87
3. Saari H, Sorsa T, Konttinen YT. Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis. Int J Tissue React 1990; 12: 81-89 (Pubitemid 20265929)
4. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987; 7: 113-122 (Pubitemid 17139714)
5. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan®) in osteoarthritis of the knee. Clin Trial J 1987; 24: 333-340 (Pubitemid 17159882)
6. Maheu E, Ayral X, Dougados M. A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 2002; 56: 804-813 (Pubitemid 36104549)
7. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 1999; 38: 602-607 (Pubitemid 29507326)
8. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993; 1: 97-103.
9. Bunyaratavej N, Chan KM, Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai 2001; 84(Suppl 2): S576-S581.
10. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993; 39: 3-9. (Pubitemid 23284286)
11. Mensitieri M, Ambrosio L, Iannace S, Nicolais L, Perbellini. A Viscoelastic evaluation for different knee osteoarthritis therapies. J Mater Sci 1995; 6: 130-137
12. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002; 32: 10-37.
13. Corrado EM, Peluso GF, Gigliotti S De Durante. C, Palmieri D, Savoia M, et al. The effects of intraarticular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 1995; 15: 47-56.
14. Shimizu C, Kubo T, Hirasawa Y, Coutts RD, Amiel D. Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis. J Rheumatol 1998; 25: 1813-1819 (Pubitemid 28439278)
15. Tamoto K, Nochi H, Tada M, Shimada S, Mori Y, Kataoka S, et al. High-molecular-weight hyaluronic acids inhibit chemotaxis and phagocytosis but not lysosomal enzyme release induced by receptor-mediated stimulations in guinea pig phagocytes. Microbiol Immunol 1994; 38: 73-80. (Pubitemid 24067690)
16. Peluso GF, Perbellini A, Tajana F. The effect of high and low molecular weight hyaluronic acid on mitogen-induced lymphocyte proliferation. Current Therapeutic Research 1990; 47: 437-443 (Pubitemid 20104052)
17. Presti D, Scott JE. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994; 12: 281-288 (Pubitemid 24350570)
18. Tobetto K, Nakai K, Akatsuka M, Yasui T, Ando T, Hirano S. Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res 1993; 29: 181-190
19. Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage 2006; 14: 814-822 (Pubitemid 43986363)
20. Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999; 28: 5-7.
21. Stitik TP, Blacksin MF, Stiskal DM, Kim JH, Foye PM, Schoenherr L, et al. Efficacy and safety of hyaluronan treatment in combination therapy with home exercise for knee osteoarthritis pain. Arch Phys Med Rehabil 2007; 88: 135-141 (Pubitemid 46161325)
22. Leardini G, Franceschini M, Mattara L, Bruno R, Perbellini A. Intra-articular sodium hyaluronate (Hyalgan) in gonarthrosis. A controlled study comparing methylprednisolone acetate. Clin Trial J 1987; 24: 341-350